Phillips-Medisize vs Jabil Healthcare: full comparison for 2026
Quick verdict
Phillips-Medisize (3.9/5) edges ahead of Jabil Healthcare (3.8/5) overall. Phillips-Medisize is the better choice for drug delivery devices needing high-volume production. Jabil Healthcare is the stronger option for global production capacity for cleared devices. The right choice depends on your project size, budget, and required tech stack.
Phillips-Medisize vs Jabil Healthcare: head-to-head summary
| Criterion | Phillips-Medisize | Jabil Healthcare |
|---|---|---|
| Founded | 1964 | 1966 |
| HQ | Hudson, WI, USA | St. Petersburg, FL, USA |
| Team size | ~7,000 | ~20,000 (healthcare) |
| Rating | 3.9 / 5 | 3.8 / 5 |
| Primary differentiator | Design, molding and assembly of drug delivery devices under one global quality system | Global scale, supply chain and FDA-registered production for established medical device brands |
| Pricing model | Development contract plus manufacturing supply agreement | Manufacturing supply agreement, NPI contract |
| Min. engagement | Not disclosed | Not disclosed |
| Primary tech stack | Injection molding, Automated assembly, BLE | Injection molding, Automated assembly, PCB assembly |
| Industries served | Drug delivery, Diagnostics & lab devices, Surgical & therapeutic devices | Surgical & robotics, Drug delivery, Wearables & remote monitoring, Consumer health |
Phillips-Medisize vs Jabil Healthcare: overview
Phillips-Medisize
Phillips-Medisize is a subsidiary of Molex, itself owned by Koch Industries, and provides outsourced design, development and manufacturing to pharma, diagnostics and medical device companies. It is based in Wisconsin and has about 7,000 employees. Molex's purchase of inhalation specialist Vectura added combination-product expertise, and the combined team includes more than 1,200 engineers and scientists across 30 sites. A $110M manufacturing campus in Katowice, Poland, opened in November 2023.
Jabil Healthcare
Jabil Healthcare was formed in 2020 when Jabil combined its Nypro business with its orthopedics, spine and trauma units. At launch it had nearly 20,000 employees and more than 35 sites, and its factories producing finished medical devices are FDA registered. It covers minimally invasive devices, surgical robotics, complex catheters, diabetes care and consumer health, and the acquisition of CDMO Pii extended it into drug development and aseptic fill-finish. Jabil reported $8.3 billion in company-wide revenue for its second fiscal quarter of 2026.
Services and capabilities: Phillips-Medisize vs Jabil Healthcare
| Capability | Phillips-Medisize | Jabil Healthcare |
|---|---|---|
| Electronics & PCB design | ✓ | ✓ |
| Firmware & embedded software | ✗ | ✗ |
| SaMD & companion apps | ✗ | ✗ |
| Connected devices & IoT | ✗ | ✗ |
| Industrial design & human factors | ✗ | ✗ |
| Mechanical engineering | ✓ | ✓ |
| Device cybersecurity | ✗ | ✗ |
| Regulatory & QMS support | ✓ | ✓ |
| Manufacturing & scale-up | ✓ | ✓ |
Tech stack comparison: Phillips-Medisize vs Jabil Healthcare
| Framework / platform | Phillips-Medisize | Jabil Healthcare |
|---|---|---|
| Embedded C/C++ | N/A | N/A |
| Embedded Linux | N/A | N/A |
| RTOS | N/A | N/A |
| BLE | ✓ | N/A |
| Cloud (AWS/Azure) | N/A | N/A |
| IEC 62304 | N/A | N/A |
| ISO 14971 | N/A | N/A |
| ISO 13485 QMS | ✓ | ✓ |
| Qt | N/A | N/A |
Pricing comparison: Phillips-Medisize vs Jabil Healthcare
| Criterion | Phillips-Medisize | Jabil Healthcare |
|---|---|---|
| Minimum engagement | Not disclosed | Not disclosed |
| Engagement models | Fixed project, Manufacturing contract | Manufacturing contract |
| Rate transparency | Not public | Not public |
| Price tier | Mid-market | Mid-market |
Target audience comparison: Phillips-Medisize vs Jabil Healthcare
| Dimension | Phillips-Medisize | Jabil Healthcare |
|---|---|---|
| Best company size | Startup to mid-market | Startup to mid-market |
| Best industries | Drug delivery, Diagnostics & lab devices, Surgical & therapeutic devices | Surgical & robotics, Drug delivery, Wearables & remote monitoring |
| Best use cases | Autoinjector or pen injector development and production, Inhaler device for a pharma combination product | Scaling production of a cleared diabetes device, Global manufacturing of a surgical robotics subsystem |
| Typical project type | Fixed project | Manufacturing contract |
Phillips-Medisize vs Jabil Healthcare: pros and cons
| Phillips-Medisize | |
|---|---|
| + | Very large manufacturing footprint across the US, Europe and Asia |
| + | Vectura deal added deep inhalation and combination-product skills |
| + | Development and manufacturing under one quality system |
| + | Experience with connected drug delivery |
| - | Owned by Molex and Koch Industries, so it suits large pharma more than small startups |
| - | Development work is usually tied to a manufacturing agreement |
| - | Less suited to software-heavy or early research projects |
| Jabil Healthcare | |
|---|---|
| + | One of the largest healthcare manufacturing networks in the world |
| + | FDA-registered sites for finished devices |
| + | Strong supply chain management during component shortages |
| + | Covers drug delivery through the Pii acquisition |
| - | Built for production volume; early design and invention are outside its main business |
| - | Small companies may struggle to get attention |
| - | Engineering support is tied to manufacturing programs |
Who should choose Phillips-Medisize?
A typical fit: autoinjector or pen injector development and production.
Design, molding and assembly of drug delivery devices under one global quality system. Minimum engagement is not publicly disclosed. Works best with clients in Drug delivery, Diagnostics & lab devices, Surgical & therapeutic devices.
Who should choose Jabil Healthcare?
A typical fit: scaling production of a cleared diabetes device.
Global scale, supply chain and FDA-registered production for established medical device brands. Minimum engagement is not publicly disclosed. Works best with clients in Surgical & robotics, Drug delivery, Wearables & remote monitoring, Consumer health.
Decision matrix: Phillips-Medisize vs Jabil Healthcare
| Your situation | Recommended choice |
|---|---|
| You need full-ownership delivery on a defined project scope | Phillips-Medisize |
| You need a large dedicated team for an ongoing programme | Check each company's engagement model |
| Your budget is at the lower end | Compare: Phillips-Medisize (Not disclosed) vs Jabil Healthcare (Not disclosed) |
| You need specialist depth in a specific vertical | Jabil Healthcare |
| You need staff augmentation or team extension | Neither; consider alternatives that offer staff aug |
| You need consulting before committing to a build | Both may offer discovery engagements |
Use case fit: Phillips-Medisize vs Jabil Healthcare
| Use case | Phillips-Medisize fit | Jabil Healthcare fit | Winner |
|---|---|---|---|
| Autoinjector or pen injector development and production | Strong | Limited | Phillips-Medisize |
| Inhaler device for a pharma combination product | Strong | Limited | Phillips-Medisize |
| Scaling production of a cleared diabetes device | Limited | Strong | Jabil Healthcare |
| Global manufacturing of a surgical robotics subsystem | Limited | Strong | Jabil Healthcare |
Verdict: Phillips-Medisize vs Jabil Healthcare
Phillips-Medisize (3.9/5) is the stronger overall choice for most Medical Device Development projects. Design, molding and assembly of drug delivery devices under one global quality system.
Jabil Healthcare (3.8/5) is worth a look if you need global manufacturing of a surgical robotics subsystem. If your situation matches that, Jabil Healthcare is a competitive option.
Related comparisons
Phillips-Medisize vs Jabil Healthcare FAQ
Is Phillips-Medisize better than Jabil Healthcare?
Phillips-Medisize (3.9/5) scores higher overall, but "better" depends on your use case. Phillips-Medisize's strongest advantage: very large manufacturing footprint across the US, Europe and Asia. Jabil Healthcare's strongest advantage: one of the largest healthcare manufacturing networks in the world.
How do Phillips-Medisize and Jabil Healthcare differ in pricing?
Phillips-Medisize uses development contract plus manufacturing supply agreement pricing. Jabil Healthcare uses manufacturing supply agreement, npi contract pricing. Neither firm publishes a full rate card; a discovery call is required for project-specific quotes.
Which is better for enterprise: Phillips-Medisize or Jabil Healthcare?
Jabil Healthcare is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each company before shortlisting.
What are the main differences between Phillips-Medisize and Jabil Healthcare?
Phillips-Medisize's primary differentiator is: Design, molding and assembly of drug delivery devices under one global quality system. Jabil Healthcare's primary differentiator is: global scale, supply chain and FDA-registered production for established medical device brands. They also differ in team size (~7,000 vs ~20,000 (healthcare)), minimum engagement (Not disclosed vs Not disclosed), and primary industries served (Drug delivery, Diagnostics & lab devices vs Surgical & robotics, Drug delivery).
Verify all details directly with each company before making a decision.